EFFECTIVENESS AND SAFETY OF SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS VEDOLIZUMAB FORMULATION IN INFLAMMATORY BOWEL DISEASE PATIENTS IN CLINICAL REMISSION: A SINGLE CENTRE REAL WORLD EXPERIENCE

Laura Parisio  ¹     Carlo Romano Settanni  ²     Simone Varca  ³     Lucrezia Laterza  ⁴     Loris Riccardo Lopetuso  ⁵     Daniele Napolitano  ⁶     Elisa Schiavoni  ⁶     Laura Turchini  ⁶     Caterina Fanali  ⁶     Norma Alfieri  ⁶     Marco Pizzoferrato  ⁷     Alfredo Papa  ⁸     Pia Clara Pafundi  ⁸     Alessandro Armuzzi  ⁹     Antonio Gasbarrini  ¹⁰     Daniela Pugliese  ¹⁰     Franco Scaldaferri  ^11    
1 IRCCS Fondazione Policlinico Gemelli Roma, Roma, Italy
² Policlinico Gemelli - Rome, Jesi, Italy
³ Fondazione Policlinico Gemelli, Roma, Italy
⁴ Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Rome, Italy
⁵ Fondazione Policlinico Universitario "A. Gemelli" IRCCS - Università Cattolica di Roma, Roma, Italy
⁶ Policlinico Gemelli - Roma, Rome, Italy
⁷ UOC Medicina Gastroenterologia, Roma, Italy
⁸ Fondazione Policlinico Gemelli,IRCCS, Rome, Italy
⁹ IBD Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
¹⁰ Fondazione Policlinico Universitario Gemelli IRCCS, Università’ Cattolica, Rome, Italy
¹¹ Catholic University of Rome Dept. of Internal Medicine Dept. of Gastroenterology, Roma, Italy

Topic
IBD

Session
PP 05 IBD (Posters)

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)